Decitabine Injection, Powder, Lyophilized, For Solution
Product Images NDC 68001-642

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Decitabine (NDC 68001-642). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Decitabine For Inj 50mg Per Vial Carton Ndc 6800164241 Rev 112024 (Decitabine For Inj 50mg Per Vial Carton Ndc 6800164241 Rev 112024)

This text provides detailed information about Decitabine for injection including its composition, reconstitution instructions, stability, dosage, storage requirements, and manufacturer details. Decitabine is a cytotoxic agent that comes in single-dose sterile vials, each containing 50 mg. It should be stored at specific temperatures and should be discarded if unused. The text also includes contact information for BluePoint Laboratories, the manufacturer of the medication.*

FDA Label Image

Decitabine For Inj 50mg Per Vial Label Ndc 6800164241 Rev 112024 (Decitabine For Inj 50mg Per Vial Label Ndc 6800164241 Rev 112024)

This text provides detailed information about a medication containing decitabine, potassium phosphate, and sodium hydroxide. The medication is for intravenous infusion only and is a cytotoxic agent. The dosage, storage instructions, and manufacturer details are also included. It is essential to follow the package insert for proper usage guidelines.*

FDA Label Image

Decitabineforinjstructure (Decitabineforinjstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.